COMMUNIQUÉS West-GlobeNewswire

Editas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases

28/02/2018 - 15:00

CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced the Company has joined forces with 30 million Americans and health care [...]

Flexion Therapeutics to Present at the 39th Annual Raymond James Institutional Investors Conference

28/02/2018 - 15:00

BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that Michael Clayman, M.D., President and Chief Executive Officer, will present at the Raymond James 39 th [...]

CV Sciences, Inc. to Present at the 30th Annual ROTH Conference in Dana Point, California, March 11-14, 2018

28/02/2018 - 14:45

LAS VEGAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI), preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, announced today that it will be presenting at [...]

BioNews Services Puts Sharp Focus on Rare Disease Day 2018

28/02/2018 - 14:45

DALLAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- BioNews Services , the leading online health, science and research publisher serving patients with rare diseases, is using its editorial resources this month in conjunction with [...]

PositiveID Announces Medical Device Subsidiary 2018 Trade Show Schedule

28/02/2018 - 14:37

DELRAY BEACH, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Diversified life sciences company, PositiveID Corporation (OTC:PSID), today announced the list of 2018 trade shows its wholly owned, professional-grade thermometer [...]

Yield10 Bioscience to Host Webcast of its 2017 Year-end Conference Call

28/02/2018 - 14:30

WOBURN, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience,Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter and full year 2017 financial results and host a conference [...]

AzurRx BioPharma to Present at the 30th Annual ROTH Conference (March 12th)

28/02/2018 - 14:30

BROOKLYN, N.Y., Feb. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

LeMaitre Vascular to Present at Upcoming Investor Conferences

28/02/2018 - 14:30

BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will be participating in seven investor conferences in March. Steven Chehames, Investor Relations, [...]

Invuity Announces Changes to Executive Leadership Team

28/02/2018 - 14:30

Scott D. Flora appointed Interim President and Chief Executive Officer Philip Sawyer steps down as President and Chief Executive Officer SAN FRANCISCO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a [...]

Rockwell Medical Announces Triferic Presentations at the 2018 Annual Dialysis Conference

28/02/2018 - 14:30

Oral and poster presentation of data for Triferic in pediatric patients and patients on intraperitoneal dialysis Conference being held March 3-6, 2018, in Orlando, Fla. WIXOM, Mich., Feb. 28, 2018 (GLOBE NEWSWIRE) -- [...]

OncBioMune Submits Phase 2 Protocol to Urology Centers of North Texas

28/02/2018 - 14:29

BATON ROUGE, La., Feb. 28, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Catalyst Pharmaceuticals Announces Its Continuing Support for Rare Disease Day 2018

28/02/2018 - 14:03

CORAL GABLES, Fla., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]

Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update

28/02/2018 - 14:00

Long Term Open Label Clinical Results Confirm That FMX101 Appears to be Safe and Well Tolerated; Continued Improvement of Treatment Effect Demonstrated at 52 Weeks Conference Call and Webcast on Wednesday, February 28, [...]

TRHC’s Coding School Accepting Applications for New Veterans Scholarship

28/02/2018 - 14:00

MOUNT PLEASANT, S.C., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (“TRHC”) (NASDAQ: TRHC ) announced today that its code school, JRS Coding School, in Mount Pleasant, SC, is now accepting applications for [...]

Sharecare Co-Founder Dr. Mehmet Oz to Present at The Conference Board’s 18th Annual Employee Health Care Conference in New York

28/02/2018 - 14:00

ATLANTA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced that its co-founder, Dr. Mehmet Oz, will be featured during a special [...]

Premier Biomedical Inc. Searching For Development Partner To Advance Patent Pending Technology

28/02/2018 - 14:00

Jackson Center, PA, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC: " BIEI ") announced today they are actively searching for a partner to develop their patented extracorporeal treatment process in [...]

Capricor to Host Key Opinion Leader Lunch on March 9

28/02/2018 - 14:00

LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced it will host a Key Opinion Leader Lunch in New York City on March 9 featuring four distinguished speakers to discuss [...]

Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer

28/02/2018 - 14:00

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]

Maple Leaf Provides Further Details on the Transfer of its Listing to the Aequitas NEO Exchange Inc.

28/02/2018 - 14:00

CALGARY, Alberta, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSX-V: MGW ) (OTCQB:MGWFF) is pleased to provide further information to the Company’s press release [...]